202 related articles for article (PubMed ID: 7290521)
1. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
Civati G; Guastoni C; Perego A; Galato R; Brando B; Grillo C; Surian M; Colussi G; Teatini U; Minetti L
Minerva Nefrol; 1981; 28(2):171-4. PubMed ID: 7290521
[No Abstract] [Full Text] [Related]
2. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
[No Abstract] [Full Text] [Related]
3. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
4. Ionised calcium during haemodialysis.
Conceicao S; Hoenich NA; Ward MK; White T; Aljama P; Dewar J; Kerr DN
Proc Eur Dial Transplant Assoc; 1977; 14():229-35. PubMed ID: 23526
[TBL] [Abstract][Full Text] [Related]
5. [Changes in serum calcium, phosphorus, calcitonin and parathormone with age and sex in normal Chinese].
Mi ZZ
Zhonghua Yi Xue Za Zhi; 1987 Aug; 67(8):444-7, 30. PubMed ID: 3123033
[No Abstract] [Full Text] [Related]
6. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
[TBL] [Abstract][Full Text] [Related]
7. [Parathormone and calcitonin in the blood in chronic kidney diseases].
Mosin VM; Iagoda AV; Salanda BS; Derevianko NA
Ter Arkh; 1982; 54(7):82-4. PubMed ID: 7135230
[No Abstract] [Full Text] [Related]
8. High- and low-flux acetate-free biofiltration: experimental assessment of calcium mass balance and intact parathyroid hormone behaviour.
de Vincenzi A; Bellazzi RG; Santagostino M; Gazo A; Romanini D; Nai M; Maretti L; Ornati G; Bellazzi R
Nephrol Dial Transplant; 1994; 9(9):1305-9. PubMed ID: 7816296
[TBL] [Abstract][Full Text] [Related]
9. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral content in cyclosporine-treated renal transplant patients.
Massari PU; Garay G; Ulla MR
Transplant Proc; 1994 Oct; 26(5):2646-8. PubMed ID: 7940826
[No Abstract] [Full Text] [Related]
11. The management of uremia.
Hamburger RJ
Am Fam Physician; 1977 Sep; 16(3):125-32. PubMed ID: 331923
[TBL] [Abstract][Full Text] [Related]
12. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone immunoreactivity in the plasma filtrate of uremic patients.
Tsutsumi M; Fukase M; Fujita T; Fujita K; Inoue S; Shin J
Miner Electrolyte Metab; 1982 Mar; 7(3):146-50. PubMed ID: 7169980
[TBL] [Abstract][Full Text] [Related]
14. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
15. [Changes in serum profile of medium molecules in patients treated with dialysis for various lengths of time].
Manari A; Buzio C; Calderini C; David S; Montagna G; Quaretti P; Gröf J; Migone L
Minerva Nefrol; 1982; 29(2):93-100. PubMed ID: 7133545
[No Abstract] [Full Text] [Related]
16. Regulation of the plasma ionized calcium and its therapeutic control in patients treated by regular hemodialysis.
Kaye M; Cohen GF; Chatterjee G; Mangel R
Trans Am Soc Artif Intern Organs; 1969; 15():341-6. PubMed ID: 5791407
[No Abstract] [Full Text] [Related]
17. Myocardial texture and cardiac calcification in uremia.
Wade MR; Chen YJ; Soliman M; Kaptein E; Massry SG; Rahimtoola SH; Chandraratna PA
Miner Electrolyte Metab; 1993; 19(1):21-4. PubMed ID: 8345830
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-, 25-OH-vitamin D-, and digoxin levels in patients treated by chronic hemofiltration.
Schaefer K; Offermann G; von Herrath D; Asmus G; Hüfler M
J Dial; 1977; 1(6):619-30. PubMed ID: 608871
[TBL] [Abstract][Full Text] [Related]
19. Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic.
Sato Y; Eriguchi R; Umakoshi J; Kato M
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S48-53. PubMed ID: 17976086
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients.
Goldstein DA; Feinstein EI; Chui LA; Pattabhiraman R; Massry SG
J Clin Endocrinol Metab; 1980 Jul; 51(1):130-4. PubMed ID: 6892917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
